PCN80 COST-EFFECTIVENESS ANALYSIS OF OXLIPLATIN IN ADJUVANT THERAPY FOR STAGE 3 COLON CANCER PATIENTS IN JAPAN
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71975-1
https://www.valueinhealthjournal.com/article/S1098-3015(11)71975-1/fulltext
Title :
PCN80 COST-EFFECTIVENESS ANALYSIS OF OXLIPLATIN IN ADJUVANT THERAPY FOR STAGE 3 COLON CANCER PATIENTS IN JAPAN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71975-1&doi=10.1016/S1098-3015(11)71975-1
First page :
A266
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
136